Medsurg Final
Medsurg Final
Medsurg Final
Complications
Hepatorenal syndrome
● Renal failure with azotemia, oliguria, and
intractable ascites
● No structural abnormality of kidneys
● Portal hypertension → vasodilation → renal
vasoconstriction
● Treat with liver transplantation
Hepatic encephalopathy
● Neurotoxic effects of ammonia
● Abnormal neurotransmission
● Astrocyte swelling
● Inflammatory cytokines
- Liver unable to convert increased ammonia
Case Study
- Ammonia crosses blood-brain barrier
● What diagnostic tests would you expect
● Changes in neurologic and mental
the health care provider to order for
responsiveness
D.L.?
● Impaired consciousness and/or
inappropriate behavior Diagnostic Studies
● Sleep disturbances to lethargy to coma ● Liver enzyme tests
● Asterixis ● Total protein, albumin levels
● Fetor hepaticus ● Serum bilirubin, globulin levels
● Cholesterol levels
● Prothrombin time
● Liver ultrasonography
● Liver biopsy
● Analysis of ascitic fluid
Case Study
● D.L.’s laboratory values are as follows:
○ Total bilirubin 11 mg/dL
○ AST 80 U/mL
○ ALT 70 U/mL
○ LDH 700 U/mL
○ Serum ammonia 220 mg/dL
○ WBC 21,450/μL
● D.L. is thin and malnourished with ascites and ● Mechanical compression of varices
marked edema on lower extremities. ● Sengstaken-Blakemore tube
● Both her liver and spleen are palpable. ● Minnesota tube
● Jaundice and spider angiomas are present. ● Linton-Nachlas tube
● There is evidence of bruising throughout her
body.
● What would be your priorities of care for D.L.?
Collaborative Care
● Rest
● Administration of B-complex vitamins
● Avoidance of alcohol, aspirin, acetaminophen,
and NSAIDs
● Considered ‘asymptomatic’
● Erosion of diverticular wall from increased ● Barium enema is contraindicated due to
intraluminal pressure →inflammation→ focal risk of perforation.
necrosis →perforation
● Usually inflammation is mild and microperforation
is walled off by pericolonic fat and mesentery
Diagnosis of Diverticulitis
Treatment of Diverticulitis
● Classic history: increasing, constant, LLQ
abdominal pain over several days prior to ● Complicated diverticulitis = Presence of
presentation with fever macroperforation, obstruction, abscess,
○ Crescendo quality – each day is worse or fistula
○ Constant – not colicky ● Uncomplicated diverticulitis = Absence
○ Fever occurs in 57-100% of cases of the above complications
● Previous of episodes of similar pain
● Associated symptoms Uncomplicated diverticulitis
○ Nausea/vomiting 20-62% ● Bowel rest or restriction
○ Constipation 50% ○ Clear liquids or NPO for 2-3 days
○ Diarrhea 25-35% ○ Then advance diet
○ Urinary symptoms (dysuria, urgency, ● Antibiotics
frequency) 10-15% ○ Coverage of fecal flora
● Right sided diverticulitis tends to cause RLQ ■ Gram negative rods,
abdominal pain; can be difficult to distinguish anaerobes
from appendicitis ○ Common regimens
● Physical examination ■ Cipro + Flagyl x 10 days
○ Low grade fever ■ Augmentin x 10 days
○ LLQ abdominal tenderness ● Monitoring clinical course
■ Usually moderate with no ○ Pain should gradually improve
peritoneal signs several days (decrescendo)
■ Painful pseudo-mass in 20% of ○ Normalization of temperature
cases ○ Tolerance of po intake
■ Rebound tenderness suggests free ● If symptoms deteriorate or fail to
perforation and peritonitis improve with 3 days, then Surgery
● Labs : Mild leukocytosis consult
○ 45% of patients will have a normal WBC ● After resolution of attack → high fiber
● Clinically, diagnosis can be made with typical diet with supplemental fiber
history and examination ● Follow-up: Colonoscopy in 4-6 weeks
● Radiographic confirmation is often performed ● Purpose:
● Abdominal CT is analysis of choice ○ Exclude neoplasm
○ Evaluate extent of the diverticulosis ○ Small abscesses too small to
● Prognosis after resolution drain percutaneously (< 1cm) can
○ 30-40% of patients will remain be treated with antibiotics alone
asymptomatic ○ These pts behave like
○ 30-40% of pts will have episodic uncomplicated diverticulitis and
abdominal cramps without frank may not require surgery
diverticulitis ● Fistulas
○ 20-30% of pts will have a second attack ○ Occurs in up to 80% of cases
○ Second attack requiring surgery
■ Risk of recurrent attacks is high ■ Major types
(>50%) ■ Colovesical fistula
■ Some studies suggest a higher rate 65%
(60%) of complications (abscess, ■ Colovaginal
fistulas, etc) in a second attack and 25%
a higher mortality rate (2x ■ Coloenteric, colouterine
compared to initial attack) 10%
○ After a second attack elective surgery Symptoms
○ Some argue in the elderly recurrent ● Passage of gas and stool from the
attacks can be managed with medications affected organ
○ Some argue elective surgery should be ● Colovesical fistula:
considered after a first attack in ○ pneumaturia, dysuria,
■ Young patients under 40-50 years fecaluria
of age ○ 50% of patients can have
■ Immunosuppressed diarrhea and passage of
urine per rectum
● Diagnosis
Complicated Diverticulitis ○ CT: thickened bladder
● Peritonitis with associated colonic
○ Resuscitation diverticuli adjacent and
○ Antibiotics air in the bladder
■ Ampicillin + Gentamycin + ○ BE: direct visualization of
Metronidazole fistula track only occurs in
■ Imipenem/cilastin 20-26% of cases
○ Emergency exploration ○ Flexible sigmoidoscopy is
○ Mortality 6% purulent peritonitis and 35% low yield (0-3%)
fecal peritonitis ○ Some argue cystoscopy
Complicated Diverticulitis: helpful
● Abscess ● Surgery
○ Occurs in 16% of patients with acute ○ Resection of affected
diverticulitis colon (origin of the
○ Percutaneous drainage followed by single fistula)
stage surgery in 60-80% of patients
○ Fistula tract can be “pinched off” ○ Accurate localization
most of the time ■ 30-47% sensitive
○ Suture closure for larger defects ■ 100% specific
○ Foley left in 7-10 days ○ Need brisk active bleeding: 0.5-1
Surgical Treatment of Diverticulitis mL/min
● Elective single stage resection is ideal, ~6 weeks ○ Offers therapy: embolization,
after episode vasopressin
● Two stage procedure (Hartmann procedure) ■ 20% risk of intestinal
Diverticular bleeding infarction
● Most common cause of brisk hematochezia (30-
50% of cases)
● 15% of patients with diverticulosis will bleed
● 75% of diverticular bleeding stops without need INFLAMMATORY BOWEL DISEASE
for intervention Inflammatory – inflammation
● Patients requiring less than 4 units of PRBC/ day Bowel – involvement of the GI system
99% will stop bleeding
An idiopathic inflammatory intestinal
● Risk of rebleeding 14-38%
disease resulting from an inappropriate
● After second episode of bleeding, risk of immune activation to host intestinal
rebleeding 21-50% microflora.
Localization
● Right colon is the source of diverticular bleeding
in 50-90% of patients
● Possible reasons
○ Right colon diverticuli have wider necks
and domes exposing vasa recta over a
great length of injury
○ Thinner wall of the right colon
● Colonoscopy after rapid prep
Different types of IBD
○ Can localize site of bleeding
1. Ulcerative Colitis
○ Offers possible therapeutic intervention Inflammation of colon
(cautery, clip, etc) Mucosal inflammation
○ Often limited by either brisk bleeding Involves colon only
obscuring lumen OR no active bleeding Continuous inflammation from anal verge
upwards
with clots in every diverticuli Bloody diarrhea
● Tagged red blood cell scan Increased risk of colon cancer
○ Can localize bleeding source
■ 97% sensitivity 2. Crohn’s Disease
Inflammation of GI tract
■ 83% specificity
Transmural segment inflammation
■ 94% PPV Involves any portion of GI tract (most
○ Can detect bleeding as slow as 0.1 mL/min commonly ileo-cecal region)
○ Often not particularly helpful Leads to strictures and fistula formation
(with peri-anal disease)
● Angiography
More abdominal pain and diarrhea, less bleeding Bloody diarrhea
Crampy abdominal pain
3. Indeterminate Colitis Tenesmus
(If the patient could not be identifies as either the two both Fever
Ulcerative colitis and crohn’s disease)
Symptoms must be present for at least 3-4
weeks, thus making UC a diagnosis of
exclusion.
Epidemiology
Has a Bimodal distribution
o UC: 3rd decade and 7th decade
o Crohn’s: 15-30 yo and 60 -70 yo
Common in Northern Europe and in Caucasians
Highest rate in Jewish Population
UC>Crohn’s
o UC: 8-15 per 100,000
o Crohn’s: 1-5 per 100,000
Etiology Pathology
Multifactorial
Mucosal Process
o Environmental
o Colonic Mucosa and submucosa are
Diet (increase intake of refined sugars)
OCP infiltrated with inflammatory cells
Alcohol drinking and smoking o Involves only the colon
o Genetics
NOD2 (Nucleotide-binding
Oligomerization Domain containing
protein 2)
ATG16L1 gene
IRGM gene
ULCERATIVE COLITIS
Pathogenesis
a.
b. Proctosigmoiditis -involves the rectum and the
sigmoid colon
c. Distal Colitis – left side of the colon.
d. Pancolitis –(universal colitis) – entire colon
Treatment: Medical
Aminosalicylates
Corticosteroids
More potent immunomodulators (Azathioprine,
Cyclosporin, Tacrolimus)
Biologic Agents (Anti-tumor necrosis factor)
Treatment: Surgical
Total Abdominal colectomy with end ileostomy
Indications for emergent surgery:
o With massive life-threatening hemorrhage
o Toxic megacolon
o Fulminant colitis who failed to respond rapidly
to medical therapy
o Deterioration in clinical condition or failure to
improve within 24 to 48 hours.
Total Proctocolectomy with end ileostomy
Indications for elective surgery
o Intractability despite maximal medical therapy
o High-risk development of major complications
of medical therapy such as aseptic necrosis of Characteristic pathologic findings
joints secondary to chronic steroid use Mucosal Ulcerations
o Significant risk of developing colorectal An inflammatory cell infiltrates
carcinoma. Noncaseating granulomas
Complications
CROHN’S DISEASE Fistula, abscess and stricture formation
Epidemiology Risk for colorectal carcinoma, if with
Bimodal incidence pancolitis
1-5 per 100,000 in North European and Caucasian
populations. Treatment: Medical
Amniosalicylates
Clinical manifestation Corticosteroids
Diarrhea More potent immunomodulators
Crampy abdominal pain (Azathioprine, cyclosporin, tacrolimus)
Fever Biologic agents (anti-tumor necrosis factor)
Weight loss Antibiotics
Perianal disease or mouth ulcers
Megaloblastic anemia Treatment: Surgical
Not curative in Crohn’s disease
Percutaneous Draining of abscess
Simple closure of secondary fistula site Corticosteroids
Removal of diseased segment of bowel A key treatment for an acute exacerbation
Resection of stricturoplasty of stricture of IBD
A topical preparation effective in mild to
Indications for surgery: moderate distal colonic disease
Internal fistula or abscess Oral preparation needed for more proximal
Obstruction or extensive disease
Fibrotic strictures IV preparation for severely ill patients
Useful for induction of remission but not for
maintenance
Extraintestinal manifestation Significant side effects with long term use
Nutrition
Parenteral nutrition
Colostomy (Diversion of fecal stream)
Crohn’s Disease
Nursing considerations
Teaching & Educations
o Stress management techniques
o Medication therapies
o Diet management & exercise
o Diagnostic testing and procedures
Support
o Understanding the disease
o Body image
Collaborate
o Dietitian
o Gastroenterologist & surgeon
o Smoking cessation programs
Gastrointestinal System
Stomach – located in the upper portion of
the abdomen
o Under the left lobe of the liver and
diaphragm
o Overlaying most of the pancreas
Causes
Contamination of food can happen at any pont of
production, growing, harvesting, processing, storing
shipping or preparing .
Cross-contamination – the transfer of harmful
organisms from one surface to another – id often the
cause. This is especially troublesome for raw, ready to
eat foods such as salads or other produce. Because
these foods aren’t cooked, harmful organisms aren’t
destroyed before eating and can cause food poisoning.
Risk factors
Wheter you become ill after eating contaminated food
depends on the organism, the amount of exposure
your age and your health. High risk groups include:
o Older adults.
o Pregnant women
o Infants and young children
o People with chronic disease
Signs and symptoms
Epigastric discomfort or pain
Nausea and vomiting
Dyspepsia
Bleeding causing hematemesis “coffee
ground” vomiting and melaena
Iron deficiency anemia (due to constant
bleeding)
PEPTIC ULCER
Involves ulceration of the mucosa of the stomach
(gastric ulcer) or the duodenum (duodenal ulcer)
Duodenal ulcers are more common.
Management
Peptic ulcer are diagnosed by endoscopy.
During endoscopy a rapid urease test (CLO
test) can be performed to check for H. pylori
(UBT)
Biopsy should be considered during
Pathophysiology endoscopy to exclude malignancy as cancers
The stomach mucosa is prone to ulceration from can look similar to ulcers during the
Breakdown of the protective layer of the stomach and procedure
duodenum Medical treatment is the same as with
Increase in stomach acid GERD, usually with high dose proton pump
There is a protective layer in the stomach comprised of mucus inhibitors. Endoscopy can be used to
and bicarbonate secreted by the stomach mucosa. This monitoring the ulcer to ensure it heals and
protective layer can be broken down by: to assess for further ulcers.
Medication (steroids or NSAIDS) Complications
Helicobacter pylori Bleeding from the ulcer is a common and
potentially life threatening complications
Perforation resulting in an acute abdomen
and peritonitis. This required urgent surgical
repair (usually laparoscopic)
Scarring and strictures of the mucosa. This can lead to
a narrowing of the pylorus (exit of the stomach)causing
difficulty in emptying the stomach contents. This is
known as pyloric stenosis. This presents with upper
abdominal pain, distention, nausea and vomiting,
particularly after eating.